apac insulin market

APAC Insulin Market, Market Segmented, by Product (Rapid acting, Long acting, Premixed, Premixed analog, Short acting, and Intermediate acting), by Application (Type I and Other Diabetes, and Type II Diabetes), and by Source (Human Recombinant, and Analogs)- Growth, Trends and Forecast, 2019-2028

  • Published Date: 2022-12-26
  • Report ID: 138327
  • Pages: 200
  • Format: prudent report format

Report Overview

The APAC Insulin Market, market size stood at around USD $15.40 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Insulinis a pancreatic hormone that is secreted by beta-cells of the islets of Langerhans and is essential for the metabolism of glucose. Diabetes mellitus type 1 is caused byinsulindeficiency while diabetes type 2 is caused by a combination ofinsulindeficiency and resistance



Market Drivers

Growing regional prevalence of diabetes, increasing market penetration rates of modern insulin products in emerging markets such as India and China is expected to drive market growth during the forecast period


1. APAC Insulin Market Overview
A. Market Size
2. APAC Insulin Market Growth Drivers and Restraints
A. Increasing market penetration rates of modern insulin products in emerging markets such as India and China
B. Growing regional prevalence of diabetes
3. APAC Insulin Market Segmentation
A. By Product
I. Rapid acting
II. Long acting
III. Premixed
IV. Premixed analog
V. Short acting
VI. Intermediate acting
B. By Application
I. Type I and Other Diabetes
II. Type II Diabetes
C. By Source
I. Human Recombinant
II. Analogs
4. APAC Insulin Market Share
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. Novo Nordisk, Company overview, Product & Services, Strategies & Financials
B. Eli and Lilly, Company overview, Product & Services, Strategies & Financials
C. Sanofi Aventis, Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.